Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Purpose Pharma International AB
AB
Active
Org 5593646630
Grev Turegatan 13 B, 114 46
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
4 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Purpose Pharma International AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
41M
31M
21M
10M
0M
2022: 0M
0M
2022
2023: 2M
2M
2023
2024: 7M (+250% vs 2023)
7M
+250%
2024
2025: 33M (+371% vs 2024)
33M
+371%
2025
EBITDA
SEK millions
0M
-7M
-14M
-21M
-29M
2022: -1M
-1M
2022
2023: -12M (-1100% vs 2022)
-12M
-1100%
2023
2024: -13M (-8% vs 2023)
-13M
-8%
2024
2025: -23M (-77% vs 2024)
-23M
-77%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
Revenue
32 808
7 475
2 160
0
Staff expenses
−7 090
—
—
—
EBITDA
−22 783
−13 396
−11 929
−1 136
Depreciation & amort.
—
−0
−0
−0
EBIT
−22 783
−13 396
−11 929
−1 136
Net financials
169
386
165
—
Profit before tax
−22 614
−13 010
−11 764
−1 136
Tax
—
−0
−0
−0
Net profit
−22 614
−13 010
−11 764
−1 136
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
Total assets
21 030
19 598
5 488
873
Equity
7 469
15 099
3 421
289
Long-term debt
—
0
0
0
Short-term debt
13 561
4 500
2 067
585
Total debt
13 561
4 500
2 067
585
Financial ratios
5-year trend
EBITDA margin
−69,4 %
This company
15,8 %
Market median
This company
Market median
539% below market
2022
2025
Equity ratio
35,5 %
This company
38,2 %
Market median
This company
Market median
7% below market
2022
2025
Return on equity
−302,8 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2022
2025
Net profit margin
−68,9 %
This company
8,1 %
Market median
This company
Market median
951% below market
2022
2025
Asset turnover
1,56×
This company
1,12×
Market median
This company
Market median
39% above market
2022
2025
Debt / equity
1,82×
This company
0,62×
Market median
This company
Market median
194% above market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-02-01 – 2022-12-31
View
PDF
More on Purpose Pharma International AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
